Skip to main content

DRx Choice Children daytime

NDC 68163-747 · RARITAN PHARMACEUTICALS

Generic nameDextromethorphan HBr and Guaifenesin
Dosage formLIQUID
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 200 mg/20mL; mg/20mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

68163-747-04 — 1 BOTTLE in 1 CARTON (68163-747-04) / 118 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68163-540 — Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, 68163-547 — ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl, 68163-605 — Dextromethorphan Hydrobromide and Guaifenesin, 68163-660 — dextromethorphan hbr, doxylamine succinate, 68163-661 — dextromethorphan hbr, doxylamine succinate, 68163-698 — Acetaminophen, Dextromethorphan HBr, Triprolidine HCl, 68163-737 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 68163-738 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 68163-742 — Dextromethorphan HBr, 68163-743 — Guaifenesin, 68163-748 — Guaifenesin and Phenylephrine Hcl, 68163-749 — Acetaminophen, Dextromethorphan HBr, 68163-771 — Dextromethorphan HBr, 68163-774 — Dextromethorphan HBr, 68196-033 — Guaifenesin, 68196-405 — Guaifenesin, 68196-812 — dextromethorphan HBr, guaifenesin, 68196-960 — GUAIFENESIN, 68196-996 — Guaifenesin, 68196-999 — Guaifenesin and Dextromethorphan HBR, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels